Global Hormonal drugs Market Research Report 2017-2022 by Players Regions Product Types & Applications

Global Hormonal drugs Market Research Report 2017-2022 by Players, Regions, Product Types & Applications

Chapter One Methodology and Data Source

1.1 Methodology/Research Approach

1.1.1 Research Programs/Design

1.1.2 Market Size Estimation

1.1.3 Market Breakdown and Data Triangulation

1.2 Data Source

1.2.1 Secondary Sources

1.2.2 Primary Sources

1.3 Disclaimer

Chapter Two Hormonal drugs Market Overview

2.1 Market Coverage

2.2 Global Hormonal drugs Market Sales Volume Revenue and Price 2012-2017

Chapter Three Hormonal drugs by Key Players 2012-2017

3.1 Global Hormonal drugs Sales Volume Market Share by Key Players 2012-2017

3.2 Global Hormonal drugs Revenue Share by Key Players 2012-2017

3.3 Global Key Players Hormonal drugs Key Product Model and Market Performance

3.4 Global Key Players Hormonal drugs Key Target Consumers and Market Performance

Chapter Four Hormonal drugs by Regions 2012-2017

4.1 Global Hormonal drugs Sales Market Share by Regions 2012-2017

4.2 Global Hormonal drugs Revenue Market Share by Regions 2012-2017

4.3 Global Hormonal drugs Price by Regions 2012-2017

4.4 North America

4.4.1 United States

4.4.2 Canada

4.5 Latin America

4.5.1 Mexico

4.5.2 Brazil

4.5.3 Argentina

4.5.4 Others in Latin America

4.6 Europe

4.6.1 Germany

4.6.2 United Kingdom

4.6.3 France

4.6.4 Italy

4.6.5 Spain

4.6.6 Russia

4.6.7 Netherland

4.6.8 Others in Europe

4.7 Asia & Pacific

4.7.1 China

4.7.2 Japan

4.7.3 India

4.7.4 Korea

4.7.5 Australia

4.7.6 Southeast Asia

4.7.6.1 Indonesia

4.7.6.2 Thailand

4.7.6.3 Philippines

4.7.6.4 Vietnam

4.7.6.5 Singapore

4.7.6.6 Malaysia

4.7.6.7 Others in Southeast Asia

4.8 Africa & Middle East

4.8.1 South Africa

4.8.2 Egypt

4.8.3 Turkey

4.8.4 Saudi Arabia

4.8.5 Iran

4.8.6 Others in Africa & Middle East

Chapter Five Hormonal drugs Market by Product Types

5.1 Hormonal drugs, by Glucocorticoid 2012-2017

5.1.1 Global Hormonal drugs Sales Market Share by Glucocorticoid 2012-2017

5.1.2 Global Hormonal drugs Revenue Market Share by Glucocorticoid 2012-2017

5.1.3 Global Hormonal drugs Price by Glucocorticoid 2012-2017

5.2 Hormonal drugs, by Mineralocorticoids 2012-2017

5.2.1 Global Hormonal drugs Sales Market Share by Mineralocorticoids 2012-2017

5.2.2 Global Hormonal drugs Revenue Market Share by Mineralocorticoids 2012-2017

5.2.3 Global Hormonal drugs Price by Mineralocorticoids 2012-2017

5.3 Hormonal drugs, by Aldosterone receptor antagonis 2012-2017

5.3.1 Global Hormonal drugs Sales Market Share by Aldosterone receptor antagonis 2012-2017

5.3.2 Global Hormonal drugs Revenue Market Share by Aldosterone receptor antagonis 2012-2017

5.3.3 Global Hormonal drugs Price by Aldosterone receptor antagonis 2012-2017

5.4 Hormonal drugs, by Synthetic modifier 2012-2017

5.4.1 Global Hormonal drugs Sales Market Share by Synthetic modifier 2012-2017

5.4.2 Global Hormonal drugs Revenue Market Share by Synthetic modifier 2012-2017

5.4.3 Global Hormonal drugs Price by Synthetic modifier 2012-2017

5.5 Hormonal drugs, by Thyroid hormone and thyroid me 2012-2017

5.5.1 Global Hormonal drugs Sales Market Share by Thyroid hormone and thyroid me 2012-2017

5.5.2 Global Hormonal drugs Revenue Market Share by Thyroid hormone and thyroid me 2012-2017

5.5.3 Global Hormonal drugs Price by Thyroid hormone and thyroid me 2012-2017

Chapter Six Global Key Players Profile

6.1 Alcon NV

6.1.1 Alcon NV Company Details and Competitors

6.1.2 Alcon NV Key Hormonal drugs Models and Performance

6.1.3 Alcon NV Hormonal drugs Business SWOT Analysis and Forecast

6.1.4 Alcon NV Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin

6.2 Allergan Pharmaceuticals Ireland

6.2.1 Allergan Pharmaceuticals Ireland Company Details and Competitors

6.2.2 Allergan Pharmaceuticals Ireland Key Hormonal drugs Models and Performance

6.2.3 Allergan Pharmaceuticals Ireland Hormonal drugs Business SWOT Analysis and Forecast

6.2.4 Allergan Pharmaceuticals Ireland Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin

6.3 AstraZeneca Pty Ltd

6.3.1 AstraZeneca Pty Ltd Company Details and Competitors

6.3.2 AstraZeneca Pty Ltd Key Hormonal drugs Models and Performance

6.3.3 AstraZeneca Pty Ltd Hormonal drugs Business SWOT Analysis and Forecast

6.3.4 AstraZeneca Pty Ltd Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin

6.4 Bausch & Lomb Incorporated

6.4.1 Bausch & Lomb Incorporated Company Details and Competitors

6.4.2 Bausch & Lomb Incorporated Key Hormonal drugs Models and Performance

6.4.3 Bausch & Lomb Incorporated Hormonal drugs Business SWOT Analysis and Forecast

6.4.4 Bausch & Lomb Incorporated Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin

6.5 BEECHAM GROUP PLC

6.5.1 BEECHAM GROUP PLC Company Details and Competitors

6.5.2 BEECHAM GROUP PLC Key Hormonal drugs Models and Performance

6.5.3 BEECHAM GROUP PLC Hormonal drugs Business SWOT Analysis and Forecast

6.5.4 BEECHAM GROUP PLC Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin

6.6 Berlin-Chemie AG

6.6.1 Berlin-Chemie AG Company Details and Competitors

6.6.2 Berlin-Chemie AG Key Hormonal drugs Models and Performance

6.6.3 Berlin-Chemie AG Hormonal drugs Business SWOT Analysis and Forecast

6.6.4 Berlin-Chemie AG Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin

6.7 Biofer S.p.A.

6.7.1 Biofer S.p.A. Company Details and Competitors

6.7.2 Biofer S.p.A. Key Hormonal drugs Models and Performance

6.7.3 Biofer S.p.A. Hormonal drugs Business SWOT Analysis and Forecast

6.7.4 Biofer S.p.A. Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin

6.8 Bright Future Pharmaceuticals Factory

6.8.1 Bright Future Pharmaceuticals Factory Company Details and Competitors

6.8.2 Bright Future Pharmaceuticals Factory Key Hormonal drugs Models and Performance

6.8.3 Bright Future Pharmaceuticals Factory Hormonal drugs Business SWOT Analysis and Forecast

6.8.4 Bright Future Pharmaceuticals Factory Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin

6.9 Chiesi Farmaceutici S.p.A.

6.9.1 Chiesi Farmaceutici S.p.A. Company Details and Competitors

6.9.2 Chiesi Farmaceutici S.p.A. Key Hormonal drugs Models and Performance

6.9.3 Chiesi Farmaceutici S.p.A. Hormonal drugs Business SWOT Analysis and Forecast

6.9.4 Chiesi Farmaceutici S.p.A. Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin

6.10 FARMABIOS S.P.A.

6.10.1 FARMABIOS S.P.A. Company Details and Competitors

6.10.2 FARMABIOS S.P.A. Key Hormonal drugs Models and Performance

6.10.3 FARMABIOS S.P.A. Hormonal drugs Business SWOT Analysis and Forecast

6.10.4 FARMABIOS S.P.A. Hormonal drugs Sales Volume Revenue Price Cost and Gross Margin

6.11 GLAXO WELLCOME UK LIMITED

6.12 GlaxoSmithKline Australia Pty Ltd

6.13 Herbrand PharmaChemicals GmbH

6.14 Laboratoire GlaxoSmithKline

6.15 LEO Pharma A/S

6.16 Merck Serono GmbH

6.17 Mitsubishi Tanabe Pharma Corporation

6.18 MSD Merck Sharp & Dohme AG

6.19 NANG KUANG PHARMCEUTICAL CO., LTD

6.20 Newchem S.p.A.

6.21 NEWCHEM SPA

6.22 Orion Corporation

6.23 Pfizer Italia s.r.l

6.24 Pharmacia & Upjohn Co.,

6.25 SAMCHUNDANG PHARM. CO.,LTD.

6.26 Santen Pharmaceutical Co.,Ltd.

6.27 Sicor Societa’ Italiana Corticosteroidi S.R.L

6.28 SYNMOSA BIOPHARMA CORPORATION

Chapter Seven Hormonal drugs by Appliance 2012-2017

7.1 Global Hormonal drugs Sales Market Share by Appliance 2012-2017

7.2 Pharmacy

7.3 Hospital

7.4 Department of endocrinology

7.5 Department of dermatology

7.6 infectious disease department

7.7 Consuming Habit and Preference

Chapter Eight Industry Chain and Supply Chain

8.1 Hormonal drugs Industry Chain Structure

8.1.1 R&D

8.1.2 Raw Materials (Components)

8.1.3 Manufacturing Plants

8.1.4 Regional Trading (Import Export and Local Sales)

8.1.5 Online Sales Channel

8.1.6 Offline Channel

8.1.7 End Users

8.2 Hormonal drugs Manufacturing

8.2.1 Key Components

8.2.2 Assembly Manufacturing

8.3 Consumer Preference

8.4 Behavioral Habits

8.5 Marketing Environment

Chapter Nine Global Hormonal drugs Market Size (Sales and Revenue) Forecast (2017-2022)

9.1 Global Hormonal drugs Sales (), Revenue (Million USD) Forecast (2017-2022)

9.2 Global Hormonal drugs Sales () Forecast by Regions (2017-2022)

9.3 Global Hormonal drugs Sales () Forecast by Application (2017-2022)

9.4 Global Hormonal drugs Sales () Forecast by Glucocorticoid (2017-2022)

9.5 Global Hormonal drugs Sales () Forecast by Mineralocorticoids (2017-2022)

9.6 Global Hormonal drugs Sales () Forecast by Aldosterone receptor antagonis (2017-2022)

9.7 Global Hormonal drugs Sales () Forecast by Synthetic modifier (2017-2022)

9.8 Global Hormonal drugs Sales () Forecast by Thyroid hormone and thyroid me (2017-2022)

Chapter Ten Development Trend and Research Conclusion

10.1 Development Trend

10.2 Research Conclusion

Table Global Hormonal drugs Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)

Figure Global Hormonal drugs Revenue (Million USD) and Growth Rate (2012-2017)

Figure Global Hormonal drugs Sales Volume () and Growth Rate (2012-2017)

Table Global Hormonal drugs Sales Volume () by Key Players (2012-2017)

Table Global Hormonal drugs Sales Volume Market Share by Key Players (2012-2017)

Figure Global Hormonal drugs Sales Volume Market Share by Key Players 2016

Figure Global Hormonal drugs Sales Volume Market Share by Key Players 2017

Table Global Hormonal drugs Revenue (Million USD) by Key Players (2012-2017)

Table Global Hormonal drugs Revenue Market Share by Key Players (2012-2017)

Figure Global Hormonal drugs Revenue Market Share by Key Players 2016

Figure Global Hormonal drugs Revenue Market Share by Key Players 2017

Table Global Key Players Key Product Model and Market Performance

Table Global Key Players Key Target Consumers and Market Performance

Table Global Hormonal drugs Sales () by Regions (2012-2017)

Table Global Hormonal drugs Sales Share by Regions (2012-2017)

Figure Global Hormonal drugs Sales Market Share by Regions in 2016

Figure Global Hormonal drugs Sales Market Share by Regions in 2017

Table Global Hormonal drugs Revenue (Million USD) by Regions (2012-2017)

Table Global Hormonal drugs Revenue Market Share by Regions (2012-2017)

Figure Global Hormonal drugs Revenue Market Share by Regions in 2016

Figure Global Hormonal drugs Revenue Market Share by Regions in 2017

Table Global Hormonal drugs Price () by Regions (2012-2017)

Table North America Hormonal drugs Sales () by Regions (2012-2017)

Table North America Hormonal drugs Revenue (Million USD) by Regions (2012-2017)

Table North America Hormonal drugs Sales Volume () by Key Players 2012-2017

Figure North America Hormonal drugs Sales () and Growth Rate (2012-2017)

Table Latin America Hormonal drugs Sales () by Regions (2012-2017)

Table Latin America Hormonal drugs Revenue (Million USD) by Regions (2012-2017)

Table Latin America Hormonal drugs Sales Volume () by Key Players (2012-2017)

Figure Latin America Hormonal drugs Sales () and Growth Rate (2012-2017)

Table Europe Hormonal drugs Sales () by Regions (2012-2017)

Table Europe Hormonal drugs Revenue (Million USD) by Regions (2012-2017)

Table Europe Hormonal drugs Sales Volume () by Key Players (2012-2017)

Figure Europe Hormonal drugs Sales () and Growth Rate (2012-2017)

Table Asia & Pacific Hormonal drugs Sales () by Regions (2012-2017)

Table Asia & Pacific Hormonal drugs Revenue (Million USD) by Regions (2012-2017)

Table Asia & Pacific Hormonal drugs Sales Volume () by Key Players (2012-2017)

Figure Asia & Pacific Hormonal drugs Sales () and Growth Rate (2012-2017)

Table Africa & Middle East Hormonal drugs Sales () by Regions (2012-2017)

Table Africa & Middle East Hormonal drugs Revenue (Million USD) by Regions (2012-2017)

Table Africa & Middle East Hormonal drugs Sales Volume () by Key Players (2012-2017)

Figure Africa & Middle East Hormonal drugs Sales () and Growth Rate (2012-2017)

Table Global Hormonal drugs Sales () by Glucocorticoid (2012-2017)

Table Global Hormonal drugs Sales Market Share by Glucocorticoid (2012-2017)

Figure Global Hormonal drugs Sales Market Share by Glucocorticoid in 2016

Table Global Hormonal drugs Revenue (Million USD) by Glucocorticoid (2012-2017)

Table Global Hormonal drugs Revenue Market Share by Glucocorticoid (2012-2017)

Figure Global Hormonal drugs Revenue Market Share by Glucocorticoid in 2016

Table Global Hormonal drugs Price () by Glucocorticoid (2012-2017)

Table Top Players of Cortisone Hormonal drugs Products List

Figure Global Cortisone Hormonal drugs Sales () and Growth Rate (2012-2017)

Table Global Hormonal drugs Sales () by Mineralocorticoids (2012-2017)

Table Global Hormonal drugs Sales Market Share by Mineralocorticoids (2012-2017)

Figure Global Hormonal drugs Sales Market Share by Mineralocorticoids in 2016

Table Global Hormonal drugs Revenue (Million USD) by Mineralocorticoids (2012-2017)

Table Global Hormonal drugs Revenue Market Share by Mineralocorticoids (2012-2017)

Figure Global Hormonal drugs Revenue Market Share by Mineralocorticoids in 2016

Table Global Hormonal drugs Price () by Mineralocorticoids (2012-2017)

Table Top Players of Fludrocortisone Hormonal drugs Products List

Figure Global Fludrocortisone Hormonal drugs Sales () and Growth Rate (2012-2017)

Table Global Hormonal drugs Sales () by Aldosterone receptor antagonis (2012-2017)

Table Global Hormonal drugs Sales Market Share by Aldosterone receptor antagonis (2012-2017)

Figure Global Hormonal drugs Sales Market Share by Aldosterone receptor antagonis in 2016

Table Global Hormonal drugs Revenue (Million USD) by Aldosterone receptor antagonis (2012-2017)

Table Global Hormonal drugs Revenue Market Share by Aldosterone receptor antagonis (2012-2017)

Figure Global Hormonal drugs Revenue Market Share by Aldosterone receptor antagonis in 2016

Table Global Hormonal drugs Price () by Aldosterone receptor antagonis (2012-2017)

Table Top Players of Spironolactone Hormonal drugs Products List

Figure Global Spironolactone Hormonal drugs Sales () and Growth Rate (2012-2017)

Table Global Hormonal drugs Sales () by Synthetic modifier (2012-2017)

Table Global Hormonal drugs Sales Market Share by Synthetic modifier (2012-2017)

Figure Global Hormonal drugs Sales Market Share by Synthetic modifier in 2016

Table Global Hormonal drugs Revenue (Million USD) by Synthetic modifier (2012-2017)

Table Global Hormonal drugs Revenue Market Share by Synthetic modifier (2012-2017)

Figure Global Hormonal drugs Revenue Market Share by Synthetic modifier in 2016

Table Global Hormonal drugs Price () by Synthetic modifier (2012-2017)

Table Top Players of Trilostane Hormonal drugs Products List

Figure Global Trilostane Hormonal drugs Sales () and Growth Rate (2012-2017)

Table Global Hormonal drugs Sales () by Thyroid hormone and thyroid me (2012-2017)

Table Global Hormonal drugs Sales Market Share by Thyroid hormone and thyroid me (2012-2017)

Figure Global Hormonal drugs Sales Market Share by Thyroid hormone and thyroid me in 2016

Table Global Hormonal drugs Revenue (Million USD) by Thyroid hormone and thyroid me (2012-2017)

Table Global Hormonal drugs Revenue Market Share by Thyroid hormone and thyroid me (2012-2017)

Figure Global Hormonal drugs Revenue Market Share by Thyroid hormone and thyroid me in 2016

Table Global Hormonal drugs Price () by Thyroid hormone and thyroid me (2012-2017)

Table Top Players of Thyroid Tablets Hormonal drugs Products List

Figure Global Thyroid Tablets Hormonal drugs Sales () and Growth Rate (2012-2017)

Table Alcon NV Company Details and Competitors

Table Alcon NV Key Hormonal drugs Models and Performance

Table Alcon NV Hormonal drugs Business SWOT Analysis and Forecast

Table Alcon NV Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure Alcon NV Hormonal drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure Alcon NV Hormonal drugs Sales Market Share (%) in Global (2012-2017)

Figure Alcon NV Hormonal drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure Alcon NV Hormonal drugs Revenue Market Share (%) in Global (2012-2017)

Table Allergan Pharmaceuticals Ireland Company Details and Competitors

Table Allergan Pharmaceuticals Ireland Key Hormonal drugs Models and Performance

Table Allergan Pharmaceuticals Ireland Hormonal drugs Business SWOT Analysis and Forecast

Table Allergan Pharmaceuticals Ireland Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure Allergan Pharmaceuticals Ireland Hormonal drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure Allergan Pharmaceuticals Ireland Hormonal drugs Sales Market Share (%) in Global (2012-2017)

Figure Allergan Pharmaceuticals Ireland Hormonal drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure Allergan Pharmaceuticals Ireland Hormonal drugs Revenue Market Share (%) in Global (2012-2017)

Table AstraZeneca Pty Ltd Company Details and Competitors

Table AstraZeneca Pty Ltd Key Hormonal drugs Models and Performance

Table AstraZeneca Pty Ltd Hormonal drugs Business SWOT Analysis and Forecast

Table AstraZeneca Pty Ltd Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure AstraZeneca Pty Ltd Hormonal drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure AstraZeneca Pty Ltd Hormonal drugs Sales Market Share (%) in Global (2012-2017)

Figure AstraZeneca Pty Ltd Hormonal drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure AstraZeneca Pty Ltd Hormonal drugs Revenue Market Share (%) in Global (2012-2017)

Table Bausch & Lomb Incorporated Company Details and Competitors

Table Bausch & Lomb Incorporated Key Hormonal drugs Models and Performance

Table Bausch & Lomb Incorporated Hormonal drugs Business SWOT Analysis and Forecast

Table Bausch & Lomb Incorporated Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure Bausch & Lomb Incorporated Hormonal drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure Bausch & Lomb Incorporated Hormonal drugs Sales Market Share (%) in Global (2012-2017)

Figure Bausch & Lomb Incorporated Hormonal drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure Bausch & Lomb Incorporated Hormonal drugs Revenue Market Share (%) in Global (2012-2017)

Table BEECHAM GROUP PLC Company Details and Competitors

Table BEECHAM GROUP PLC Key Hormonal drugs Models and Performance

Table BEECHAM GROUP PLC Hormonal drugs Business SWOT Analysis and Forecast

Table BEECHAM GROUP PLC Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure BEECHAM GROUP PLC Hormonal drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure BEECHAM GROUP PLC Hormonal drugs Sales Market Share (%) in Global (2012-2017)

Figure BEECHAM GROUP PLC Hormonal drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure BEECHAM GROUP PLC Hormonal drugs Revenue Market Share (%) in Global (2012-2017)

Table Berlin-Chemie AG Company Details and Competitors

Table Berlin-Chemie AG Key Hormonal drugs Models and Performance

Table Berlin-Chemie AG Hormonal drugs Business SWOT Analysis and Forecast

Table Berlin-Chemie AG Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure Berlin-Chemie AG Hormonal drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure Berlin-Chemie AG Hormonal drugs Sales Market Share (%) in Global (2012-2017)

Figure Berlin-Chemie AG Hormonal drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure Berlin-Chemie AG Hormonal drugs Revenue Market Share (%) in Global (2012-2017)

Table Biofer S.p.A. Company Details and Competitors

Table Biofer S.p.A. Key Hormonal drugs Models and Performance

Table Biofer S.p.A. Hormonal drugs Business SWOT Analysis and Forecast

Table Biofer S.p.A. Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure Biofer S.p.A. Hormonal drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure Biofer S.p.A. Hormonal drugs Sales Market Share (%) in Global (2012-2017)

Figure Biofer S.p.A. Hormonal drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure Biofer S.p.A. Hormonal drugs Revenue Market Share (%) in Global (2012-2017)

Table Bright Future Pharmaceuticals Factory Company Details and Competitors

Table Bright Future Pharmaceuticals Factory Key Hormonal drugs Models and Performance

Table Bright Future Pharmaceuticals Factory Hormonal drugs Business SWOT Analysis and Forecast

Table Bright Future Pharmaceuticals Factory Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure Bright Future Pharmaceuticals Factory Hormonal drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure Bright Future Pharmaceuticals Factory Hormonal drugs Sales Market Share (%) in Global (2012-2017)

Figure Bright Future Pharmaceuticals Factory Hormonal drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure Bright Future Pharmaceuticals Factory Hormonal drugs Revenue Market Share (%) in Global (2012-2017)

Table Chiesi Farmaceutici S.p.A. Company Details and Competitors

Table Chiesi Farmaceutici S.p.A. Key Hormonal drugs Models and Performance

Table Chiesi Farmaceutici S.p.A. Hormonal drugs Business SWOT Analysis and Forecast

Table Chiesi Farmaceutici S.p.A. Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure Chiesi Farmaceutici S.p.A. Hormonal drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure Chiesi Farmaceutici S.p.A. Hormonal drugs Sales Market Share (%) in Global (2012-2017)

Figure Chiesi Farmaceutici S.p.A. Hormonal drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure Chiesi Farmaceutici S.p.A. Hormonal drugs Revenue Market Share (%) in Global (2012-2017)

Table FARMABIOS S.P.A. Company Details and Competitors

Table FARMABIOS S.P.A. Key Hormonal drugs Models and Performance

Table FARMABIOS S.P.A. Hormonal drugs Business SWOT Analysis and Forecast

Table FARMABIOS S.P.A. Hormonal drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure FARMABIOS S.P.A. Hormonal drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure FARMABIOS S.P.A. Hormonal drugs Sales Market Share (%) in Global (2012-2017)

Figure FARMABIOS S.P.A. Hormonal drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure FARMABIOS S.P.A. Hormonal drugs Revenue Market Share (%) in Global (2012-2017)

Table GLAXO WELLCOME UK LIMITED Company Details and Competitors

Table GlaxoSmithKline Australia Pty Ltd Company Details and Competitors

Table Herbrand PharmaChemicals GmbH Company Details and Competitors

Table Laboratoire GlaxoSmithKline Company Details and Competitors

Table LEO Pharma A/S Company Details and Competitors

Table Merck Serono GmbH Company Details and Competitors

Table Mitsubishi Tanabe Pharma Corporation Company Details and Competitors

Table MSD Merck Sharp & Dohme AG Company Details and Competitors

Table NANG KUANG PHARMCEUTICAL CO., LTD Company Details and Competitors

Table Newchem S.p.A. Company Details and Competitors

Table NEWCHEM SPA Company Details and Competitors

Table Orion Corporation Company Details and Competitors

Table Pfizer Italia s.r.l Company Details and Competitors

Table Pharmacia & Upjohn Co., Company Details and Competitors

Table SAMCHUNDANG PHARM. CO.,LTD. Company Details and Competitors

Table Santen Pharmaceutical Co.,Ltd. Company Details and Competitors

Table Sicor Societa’ Italiana Corticosteroidi S.R.L Company Details and Competitors

Table SYNMOSA BIOPHARMA CORPORATION Company Details and Competitors

Table Global Hormonal drugs Sales () by Appliance (2012-2017)

Figure Global Hormonal drugs Sales Market Share by Appliance (2012-2017)

Figure Global Hormonal drugs Sales Market Share by Appliance in 2016

Figure Global Pharmacy Hormonal drugs Sales () and Growth Rate (2012-2017)

Figure Global Hospital Hormonal drugs Sales () and Growth Rate (2012-2017)

Figure Global Department of endocrinology Hormonal drugs Sales () and Growth Rate (2012-2017)

Figure Global Department of dermatology Hormonal drugs Sales () and Growth Rate (2012-2017)

Figure Global infectious disease department Hormonal drugs Sales () and Growth Rate (2012-2017)

Figure Global Hormonal drugs Sales () and Growth Rate (%) Forecast (2017-2022)

Figure Global Hormonal drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global Hormonal drugs Price () Trend Forecast (2017-2022)

Table Global Hormonal drugs Sales () Forecast by Regions (2017-2022)

Table Global Hormonal drugs Sales Volume Share Forecast by Regions (2017-2022)

Figure Global Hormonal drugs Sales Volume Share Forecast by Regions (2017-2022)

Figure Global Hormonal drugs Sales Volume Share Forecast by Regions in 2022

Table Global Hormonal drugs Sales () Forecast by Application (2017-2022)

Figure Global Hormonal drugs Sales Volume Market Share Forecast by Application (2017-2022)

Figure Global Hormonal drugs Sales Volume Market Share Forecast by Application in 2022

Table Global Hormonal drugs Sales () Forecast by Glucocorticoid (2017-2022)

Figure Global Hormonal drugs Sales () Forecast by Glucocorticoid (2017-2022)

Figure Global Hormonal drugs Sales Volume Market Share Forecast by Glucocorticoid in 2022

Table Global Hormonal drugs Sales () Forecast by Mineralocorticoids (2017-2022)

Figure Global Hormonal drugs Sales () Forecast by Mineralocorticoids (2017-2022)

Figure Global Hormonal drugs Sales Volume Market Share Forecast by Mineralocorticoids in 2022

Table Global Hormonal drugs Sales () Forecast by Aldosterone receptor antagonis (2017-2022)

Figure Global Hormonal drugs Sales () Forecast by Aldosterone receptor antagonis (2017-2022)

Figure Global Hormonal drugs Sales Volume Market Share Forecast by Aldosterone receptor antagonis in 2022

Table Global Hormonal drugs Sales () Forecast by Synthetic modifier (2017-2022)

Figure Global Hormonal drugs Sales () Forecast by Synthetic modifier (2017-2022)

Figure Global Hormonal drugs Sales Volume Market Share Forecast by Synthetic modifier in 2022

Table Global Hormonal drugs Sales () Forecast by Thyroid hormone and thyroid me (2017-2022)

Figure Global Hormonal drugs Sales () Forecast by Thyroid hormone and thyroid me (2017-2022)

Figure Global Hormonal drugs Sales Volume Market Share Forecast by Thyroid hormone and thyroid me in 2022